Intech Biopharm Corporation 6461.TWO Stock
Intech Biopharm Corporation Price Chart
Intech Biopharm Corporation 6461.TWO Financial and Trading Overview
| Intech Biopharm Corporation stock price | 27.65 TWD |
| Previous Close | 33.75 TWD |
| Open | 33.7 TWD |
| Bid | 34 TWD x 0 |
| Ask | 34.05 TWD x 0 |
| Day's Range | 33.45 - 34.5 TWD |
| 52 Week Range | 23.2 - 46.75 TWD |
| Volume | 565.02K TWD |
| Avg. Volume | 1.11M TWD |
| Market Cap | 3.98B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.81 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6461.TWO Valuation Measures
| Enterprise Value | 3.95B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.8601065 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Intech Biopharm Corporation Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 37.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 46.75 TWD |
| 52 Week Low | 23.2 TWD |
| 50-Day Moving Average | 35.26 TWD |
| 200-Day Moving Average | 33.99 TWD |
6461.TWO Share Statistics
| Avg. Volume (3 month) | 1.11M TWD |
| Avg. Daily Volume (10-Days) | 493.1K TWD |
| Shares Outstanding | 116.93M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 46.97% |
| % Held by Institutions | 6.25% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 0.2 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -147262000 TWD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -2.9 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 8.821 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Intech Biopharm Corporation
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 36, Ruiguang Road |
| ZIP | 114 |
| Phone | 886 2 7721 8877 |
| Website | https://www.intechbiopharm.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 88 |
Intech Biopharm Corporation focuses on developing and manufacturing generic drugs to treat respiratory diseases. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and chronic pulmonary obstructive disease; and dry powder inhaler, a product comprises of blisters and capsules. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.
Q&A For Intech Biopharm Corporation Stock
What is a current 6461.TWO stock price?
Intech Biopharm Corporation 6461.TWO stock price today per share is 27.65 TWD.
How to purchase Intech Biopharm Corporation stock?
You can buy 6461.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Intech Biopharm Corporation?
The stock symbol or ticker of Intech Biopharm Corporation is 6461.TWO.
Which industry does the Intech Biopharm Corporation company belong to?
The Intech Biopharm Corporation industry is Biotechnology.
How many shares does Intech Biopharm Corporation have in circulation?
The max supply of Intech Biopharm Corporation shares is 137.41M.
What is Intech Biopharm Corporation Price to Earnings Ratio (PE Ratio)?
Intech Biopharm Corporation PE Ratio is now.
What was Intech Biopharm Corporation earnings per share over the trailing 12 months (TTM)?
Intech Biopharm Corporation EPS is -2.81 TWD over the trailing 12 months.
Which sector does the Intech Biopharm Corporation company belong to?
The Intech Biopharm Corporation sector is Healthcare.